BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 25151304)

  • 1. Effects of atomoxetine on attention and impulsivity in the five-choice serial reaction time task in rats with lesions of dorsal noradrenergic ascending bundle.
    Liu YP; Huang TS; Tung CS; Lin CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():81-90. PubMed ID: 25151304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test.
    Navarra R; Graf R; Huang Y; Logue S; Comery T; Hughes Z; Day M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):34-41. PubMed ID: 17714843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of noradrenaline re-uptake sites improves accuracy and impulse control in rats performing a five-choice serial reaction time tasks.
    Robinson ES
    Psychopharmacology (Berl); 2012 Jan; 219(2):303-12. PubMed ID: 21800042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atomoxetine decreases vulnerability to develop compulsivity in high impulsive rats.
    Ansquer S; Belin-Rauscent A; Dugast E; Duran T; Benatru I; Mar AC; Houeto JL; Belin D
    Biol Psychiatry; 2014 May; 75(10):825-32. PubMed ID: 24252357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impulsive action and impulsive choice are mediated by distinct neuropharmacological substrates in rat.
    Paterson NE; Wetzler C; Hackett A; Hanania T
    Int J Neuropsychopharmacol; 2012 Nov; 15(10):1473-87. PubMed ID: 22094071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sub-optimal performance in the 5-choice serial reaction time task in rats was sensitive to methylphenidate, atomoxetine and d-amphetamine, but unaffected by the COMT inhibitor tolcapone.
    Paterson NE; Ricciardi J; Wetzler C; Hanania T
    Neurosci Res; 2011 Jan; 69(1):41-50. PubMed ID: 20934466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociable effects of monoamine reuptake inhibitors on distinct forms of impulsive behavior in rats.
    Baarendse PJ; Vanderschuren LJ
    Psychopharmacology (Berl); 2012 Jan; 219(2):313-26. PubMed ID: 22134476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential roles for cortical versus sub-cortical noradrenaline and modulation of impulsivity in the rat.
    Benn A; Robinson ES
    Psychopharmacology (Berl); 2017 Jan; 234(2):255-266. PubMed ID: 27744551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-injury atomoxetine treatment improves cognition following experimental traumatic brain injury.
    Reid WM; Hamm RJ
    J Neurotrauma; 2008 Mar; 25(3):248-56. PubMed ID: 18352838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat.
    Robinson ES; Eagle DM; Mar AC; Bari A; Banerjee G; Jiang X; Dalley JW; Robbins TW
    Neuropsychopharmacology; 2008 Apr; 33(5):1028-37. PubMed ID: 17637611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat.
    Swanson CJ; Perry KW; Koch-Krueger S; Katner J; Svensson KA; Bymaster FP
    Neuropharmacology; 2006 May; 50(6):755-60. PubMed ID: 16427661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic atomoxetine treatment during adolescence decreases impulsive choice, but not impulsive action, in adult rats and alters markers of synaptic plasticity in the orbitofrontal cortex.
    Sun H; Cocker PJ; Zeeb FD; Winstanley CA
    Psychopharmacology (Berl); 2012 Jan; 219(2):285-301. PubMed ID: 21809008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of ADHD medications on impulsive action in the mouse 5-choice serial reaction time task.
    Fitzpatrick CM; Andreasen JT
    Eur J Pharmacol; 2019 Mar; 847():123-129. PubMed ID: 30690006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atomoxetine blocks motor hyperactivity in neonatal 6-hydroxydopamine-lesioned rats: implications for treatment of attention-deficit hyperactivity disorder.
    Moran-Gates T; Zhang K; Baldessarini RJ; Tarazi FI
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):439-44. PubMed ID: 15817135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in noradrenergic modulation of attention and impulsivity in rats.
    Mei X; Wang L; Yang B; Li X
    Psychopharmacology (Berl); 2021 Aug; 238(8):2167-2177. PubMed ID: 33834255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pay attention to impulsivity: modelling low attentive and high impulsive subtypes of adult ADHD in the 5-choice continuous performance task (5C-CPT) in female rats.
    Tomlinson A; Grayson B; Marsh S; Harte MK; Barnes SA; Marshall KM; Neill JC
    Eur Neuropsychopharmacol; 2014 Aug; 24(8):1371-80. PubMed ID: 24882551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of serotonin and/or noradrenaline reuptake inhibitors on impulsive-like action assessed by the three-choice serial reaction time task: a simple and valid model of impulsive action using rats.
    Tsutsui-Kimura I; Ohmura Y; Izumi T; Yamaguchi T; Yoshida T; Yoshioka M
    Behav Pharmacol; 2009 Sep; 20(5-6):474-83. PubMed ID: 19730368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of atomoxetine on attention in Wistar rats treated with the neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4).
    Hauser J; Reissmann A; Sontag TA; Tucha O; Lange KW
    Atten Defic Hyperact Disord; 2017 Dec; 9(4):253-262. PubMed ID: 28293899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atomoxetine reduces hyperactive/impulsive behaviours in neurokinin-1 receptor 'knockout' mice.
    Pillidge K; Porter AJ; Vasili T; Heal DJ; Stanford SC
    Pharmacol Biochem Behav; 2014 Dec; 127():56-61. PubMed ID: 25450119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists.
    Fernando AB; Economidou D; Theobald DE; Zou MF; Newman AH; Spoelder M; Caprioli D; Moreno M; Hipólito L; Aspinall AT; Robbins TW; Dalley JW
    Psychopharmacology (Berl); 2012 Jan; 219(2):341-52. PubMed ID: 21761147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.